Answers are grounded in this paper and cite their sources.
Two novel steroidal saponins, Trilliumosides A ( 1 ) and B ( 2 ) were isolated from the rhizomes of Trillium govanianum by bioactivity-guided phytochemical investigation along with seven known compounds protodioscin ( 3 ) govanoside B ( 4 ), borassoside E ( 5 ), 20-hydroxyecdysone ( 6 ), 5-20-hydroxyecdysone ( 7 ), govanic acid ( 8 ), and diosgenin ( 9 ). The structure of novel compounds 1-2 were established using spectroscopic methods such as 1D, 2D NMR data and HR-ESI-MS. The isolated compounds were evaluated for in-vitro cytotoxic activity against a panel of human cancer cell lines. Compound 1 showed significant cytotoxic activity against A-549 (Lung) and SW-620 (Colon) cell lines with IC 50 values of 1.83 and 1.85 µM, whereas compound (2) IC 50 value against A-549 cell line was found to be 1.79 µM. Among previously known compounds (3), (5) and (9) their cytotoxic IC 50 value was found to be in the range of 5-10 µM. In detailed anticancer analysis compound (2) was seen inhibiting colony forming potential and in-vitro migration in the A-549 cell line. Furthermore, the mechanistic study of compound (2) on the A-549 cell line revealed characteristic changes including nuclear morphology, increased ROS generation, and reduced levels of MMP. Above mentioned events eventually induce apoptosis, a key hallmark in cancer studies, by upregulating the pro-apoptotic protein BAX and downregulating the anti-apoptotic protein BCL-2 thereby activating Caspase-3. Our study reports the first mechanistic anticancer evaluation of the compounds isolated from the rhizomes of Trillium govanianum with remarkable activity in the desired micro molar range.
No takes yet. Share an insight, caveat, or question.
Lone et al. (2023) studied this question.